Price change of branded drugs U.S. 2011-2018

This statistic shows the average price change for branded drugs in the United States between 2011 and 2018. During 2015, the invoice price for brand drugs increased nearly 12 percent while the estimated net price, which reflects impact of off-invoice rebates and discounts provided by manufacturers, increased 2.4 percent.

Average price growth for branded drugs in the U.S. from 2011 to 2018*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

July 2019

Region

United States

Survey time period

2011 to 2018

Supplementary notes

* Includes protected brand medicines only (ie, brand medicines without generic versions available in the year indicated).
** Estimated net price growth reflects impact of off-invoice rebates and discounts provided by manufacturers.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.